Question 1

What is Arrowhead Pharmaceuticals?

Accepted Answer

Arrowhead Pharmaceuticals is a Company.

Question 2

How often does Arrowhead Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 19 articles.

Question 3

When was Arrowhead Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Apr 29, 2026.

Question 4

When was Arrowhead Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on May 26, 2026.

Question 5

What is Arrowhead Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 23 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Arrowhead Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Arrowhead Pharmaceuticals?

Accepted Answer

Arrowhead Presents Positive Plozasiran Data (May 26, 2026, 6 articles).

Question 8

How did the "Arrowhead Presents Positive Plozasiran Data" event impact Arrowhead Pharmaceuticals?

Accepted Answer

Arrowhead Pharmaceuticals presented positive clinical data for plozasiran, supporting its broader use and potential for sustained triglyceride lowering, which could enhance the drug's market potential and the company's stock value.

Question 9

How did the "Codexis Advances RNA Manufacturing Platform" event impact Arrowhead Pharmaceuticals?

Accepted Answer

Arrowhead Pharmaceuticals participated in a panel discussion, emphasizing the importance of stereochemical control in RNAi manufacturing.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.